GlassScriptPhysician profile
Kathryn Oubre
NPI 1639248669
$7,198.62
in general payments reported to CMS, 2019-2025
19 companies · $1,228 in 2025
The $1,228 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2021: $393 · 2022: $427 · 2023: $1,566 · 2024: $3,336 · 2025: $1,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,500 · Consulting Fee: $1,750 · Food and Beverage: $1,077 · Travel and Lodging: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,500.00 |
| Consulting Fee | $1,750.00 |
| Food and Beverage | $1,077.49 |
| Travel and Lodging | $802.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $3,302.03 | 2024 | |
| Mirati Therapeutics, INC. | $1,050.00 | 2023 | Krazati |
| Beone Medicines USA, INC. | $700.00 | 2025 | Brukinsa |
| Amgen INC. | $349.33 | 2021-2025 | |
| Novo Nordisk INC | $324.89 | 2022-2025 | Wegovy |
| Organon LLC | $193.31 | 2022 | |
| Tris Pharma INC | $125.00 | 2023 | Quillichew Er, Quillivant, Dyanavel Xr |
| Celgene Corporation | $125.00 | 2019 | |
| Rigel Pharmaceuticals, INC. | $124.99 | 2023 | Tavalisse, Rezlidhia |
| Bayer Healthcare Pharmaceuticals INC. | $124.84 | 2019 | |
| Asd Specialty Healthcare, LLC | $124.70 | 2025 | |
| Abbvie INC. | $116.36 | 2024-2025 | |
| Daiichi Sankyo INC. | $108.32 | 2021 | |
| Dova Pharmaceuticals | $105.64 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $100.56 | 2022-2023 | Imbruvica |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $98.60 | 2023 | Inspire |
| Exact Sciences Corporation | $88.20 | 2025 | The Cologuard Plus Collection Kit |
| Deciphera Pharmaceuticals INC. | $19.59 | 2022 | |
| Incyte Corporation | $17.26 | 2025 | Jakafi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Oubre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.